Raconteur Global Resources Limited's Board of Directors has approved a preferential issue of 17.05 million convertible warrants worth ₹290 million and 588,235 equity shares worth ₹10 million at ₹17 per unit. The proposal is subject to shareholder approval at the company's AGM on August 27, 2026.
MUMBAI — Raconteur Global Resources Limited announced that its Board of Directors has approved a fundraising plan totaling approximately ₹300 million (₹30 crore) through the issuance of convertible warrants and equity shares on a preferential basis. The board approved the capital-raising proposal during its meeting held on Thursday, July 30, 2026, according to a regulatory filing submitted to BSE Limited.
The capital infusion aims to strengthen the Mumbai-headquartered company's financial structure and support corporate growth initiatives, subject to shareholder approval at its upcoming Annual General Meeting (AGM) scheduled for August 27, 2026.
Breakdown of Preferential Warrant and Share Issuance
The corporate fundraising comprises two distinct capital instruments directed toward public and non-promoter investors:
1. Convertible Warrants Issuance
The Board approved the issuance of up to 17,058,818 warrants convertible into an equivalent number of equity shares of face value ₹10 each. The warrants will be issued at a price of ₹17 per warrant, which includes a premium of ₹7 per share. The total value of the warrant issue aggregates to ₹28,99,99,906 (approximately ₹290 million).
Each convertible warrant can be exercised into one equity share within 18 months from the date of allotment, in one or more tranches, upon full payment of the issue price. The allotment will cover 14 non-promoter entities and individuals, including Boolean Ventura Private Limited, Grip Assets Management Private Limited, Max Biosciences Private Limited, and Nature Heavens India Private Limited.
2. Direct Equity Share Allotment
Alongside the convertible warrants, the Board approved the preferential issuance of 588,235 equity shares of face value ₹10 each at an issue price of ₹17 per share (including a premium of ₹7). The equity share allotment aggregates to ₹99,99,995 (approximately ₹10 million).
The equity shares will be allotted on a preferential basis to non-promoter investor Atharva LLP.
Regulatory Compliance and Valuation Standards
The pricing of the preferential issue was determined in accordance with Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (SEBI ICDR Regulations).
The company designated Tuesday, July 28, 2026, as the relevant date for calculating the issue price. Valuation was conducted by IBBI-registered valuer Sandeep Agrawal, who issued a formal valuation report on July 29, 2026.
In addition to capital raising, the Board approved the Directors' Report, the Management Discussion and Analysis Report (MDAR) for FY 2025-26, and the notice for the 8th AGM. Practicing Company Secretary Devender Singh has been appointed as the scrutinizer to manage the remote e-voting and ballot process.
Official Sources Section
The announcement was communicated through official regulatory disclosures submitted to Indian financial authorities and stock exchange desks:
Regulatory Filing: Submitted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Stock Exchange Listing: Listing Department,
BSE Limited(Scrip Code: 541703).
Market Regulator Guidelines: Compliance with
Securities and Exchange Board of IndiaICDR Regulations.
Quote Section
According to official filings signed by Company Secretary and Compliance Officer Radhika Sood:
"The Board of Directors at their meeting held today, i.e., on Thursday, 30th day of July, 2026... inter alia has considered and approved the issuance of 17,058,818 Warrants Convertible into equivalent number of Equity Shares... aggregating to INR 28,99,99,906/- and 588,235 Equity Shares... aggregating to INR 99,99,995/- for cash consideration on preferential basis."
Why It Matters
The total capital infusion of nearly ₹300 million will expand Raconteur Global Resources Limited's equity capitalization base upon conversion. Bringing in multiple non-promoter institutional and private investors provides fresh capital for corporate activities while preserving existing promoter holdings during the initial warrant issuance period.
Key Facts at a Glance
Board Approval Date: July 30, 2026.
Total Funds Raised: Approximately ₹300 million (₹290 million in warrants + ₹10 million in equity).
Issue Price: ₹17 per share/warrant (₹10 face value + ₹7 premium).
Warrant Conversion Window: Up to 18 months from allotment date.
AGM Date: Scheduled for August 27, 2026.
Frequently Asked Questions (FAQ)
What is the total value of the preferential issue approved by Raconteur Global Resources?
The company approved fundraising totaling approximately ₹300 million, comprising ₹289.99 million via convertible warrants and ₹10 million via equity shares.
What is the issue price for the shares and warrants?
Both the convertible warrants and equity shares are priced at ₹17 per unit, which includes a face value of ₹10 and a premium of ₹7.
When can the convertible warrants be converted into equity shares?
Warrant holders can exercise their conversion option into equity shares at any time within 18 months from the date of warrant allotment.
When will shareholders vote on the proposed preferential issue?
Shareholders will vote on the proposed issuance at the company's 8th Annual General Meeting on August 27, 2026.
Source: Official regulatory disclosures filed with BSE Limited on July 30, 2026.